ResMed Inc. (RMD) Q1 2026 Earnings Call Transcript

October 30, 2025 10:16:26 pm

Source: SeekingAlpha

2025-10-30 22:16:26 ET

ResMed Inc. (RMD) Q1 2026 Earnings Call October 30, 2025 4:30 PM EDT

Company Participants

Sallilyn Schwartz - Chief Investor Relations Officer
Michael Farrell - CEO & Chairman
Brett Sandercock - Chief Financial Officer
...

For further details see:

Resmed Inc. Chess Depository Interest

0.0% G/L:

$25.67 Last:

507 Volume:

$25.67 Open:

Market Cap $40,201,411,540

Float 146,930,660

Insiders Ownership N/A

Institutions 121

Short Percent N/A

Industry Medical Equipment & Supplies

Sector Healthcare

Country US

City San Diego